Clinical spectrum of chronic acquired demyelinating polyneuropathies. - Wikidata - wikimedia - TriplyDB

Clinical spectrum of chronic acquired demyelinating polyneuropathies.

Clinical spectrum of chronic acquired demyelinating polyneuropathies.

http://www.wikidata.org/entity/Q34251202

about

Treatment for IgG and IgA paraproteinaemic neuropathy Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy Treatment for IgG and IgA paraproteinaemic neuropathy Treatment for IgG and IgA paraproteinaemic neuropathy Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside Chronic inflammatory demyelinating polyneuropathy Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants Monoclonal Gammopathy-Associated Peripheral Neuropathy: Diagnosis and Management.Severity and patterns of blood-nerve barrier breakdown in patients with chronic inflammatory demyelinating polyradiculoneuropathy: correlations with clinical subtypes.Pattern-recognition approach to neuropathy and neuronopathy.Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy Peripheral neuropathy.Clinical characteristics of patients with diabetic polyneuropathy: the role of clinical and electromyographic evaluation and the effect of the various types on the quality of life.Different clinical, electrophysiological and immunological features of CIDP associated with paraproteinaemia.The effect of treatment upon temporal dispersion in IvIg responsive multifocal motor neuropathy Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy Treatment of immune-mediated, dysimmune neuropathies.Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.Chronic inflammatory demyelinating polyneuropathy: a treatment protocol proposal.Predicting treatment response in chronic, acquired demyelinating neuropathies.Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy.Inflammatory demyelinating neuropathies and neuropathies associated with monoclonal gammopathies: treatment update.Evidence-based treatment of chronic immune-mediated neuropathies.The myelin sheath aqueous layers improve the membrane properties of simulated chronic demyelinating neuropathies.Review of the evolution of electrodiagnostic criteria for chronic inflammatory demyelinating polyradicoloneuropathy.Anaesthetic management and implications of a case of chronic inflammatory demyelinating polyneuropathy An update on monoclonal gammopathy and neuropathy.Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies.Comparison of sensitivity and specificity among 15 criteria for chronic inflammatory demyelinating polyneuropathy.Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.A patient with amyotrophic lateral sclerosis and atypical clinical and electrodiagnostic features: a case report.Diabetic neuropathy: a clinical and neuropathological study of 107 patients.EBV-associated lymphoma and chronic inflammatory demyelinating polyneuropathy in an adult without overt immunodeficiency.Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases.The diagnosis of chronic inflammatory demyelinating polyneuropathy: a Delphi-method approach.

P2860

Q24187168-0943FC5B-2CD3-48FF-8D59-DDD0314CC37B Q24187755-A26AEC82-CF7D-4F60-A3D8-971E726A1358 Q24200900-9CA44713-808F-4A6F-8D21-EBEA2AFA16F7 Q24201954-CB5EF983-C151-4177-930F-AC0601903122 Q24236599-49E1AF5D-88D4-41BE-838E-511BFFCA2C76 Q24246371-796D2408-C075-43DE-A842-698EF9BC14A1 Q24246682-7AF92121-1577-4128-96C4-BD23DA43D471 Q24670327-CA6068B1-82AB-4E25-B33E-118A28105818 Q26823910-8B12BFB3-C104-4D51-BFF6-CE311E8BF7AA Q28384089-8244975C-C2D3-4D38-A36A-2A6FEDC83F64 Q28390264-D51D3796-8301-4047-90B8-C039FFF276DC Q30234567-A14A2357-DEC5-4060-A008-4EFFE4515310 Q34020516-B932246F-92FD-4C99-B3BC-EFFD68789036 Q34342810-0CA1548D-910F-421B-8D60-B388F7A3F1E8 Q34344264-43160C6B-BDB8-4AB8-B091-A9B61A0BB376 Q34540918-361B6DD8-8FE2-462D-B777-F9FF1D208FB7 Q34769758-71266494-8FA8-4290-9468-FB1F2900840F Q35212385-96E8185D-B1E4-442B-BFE2-C079DA1E10DC Q35489630-FC039083-0C89-457A-B9FC-8E6AFC984ECC Q36005389-80FF23E6-C54E-453F-A671-0B43F725E891 Q36092349-0022E6D8-509D-4E35-8500-2B6FDEDCAECC Q36189269-1C386C6E-0F96-4214-97A9-D7EB4F34A863 Q36365583-290FC5B0-8E5F-4933-97E6-B1A21B157D0A Q36419576-2157B5F6-CB44-425D-929F-27561CE4D1A2 Q36641529-E6B5C428-2A1A-42CB-815F-FAAC7497B0D9 Q37140095-1D16896D-8326-4333-A9FC-07A545E6D809 Q37329516-D0756C9F-38AA-4520-8A0D-8E29E72F2273 Q37550515-8F3E97D2-DBAD-42E6-A439-AFCE2BD3D565 Q37855766-7586548E-3B08-439B-8D43-AF5AC986F3B4 Q37879052-7E590591-63FE-40D8-B1C8-EB62A0AF32E4 Q37909924-B507AC83-2254-456A-8C1E-50990A73F2E6 Q37957050-5E3882B0-2A49-465A-962C-B961E4B1EB16 Q37959252-74E94B49-0232-40D3-8A5F-6F08BC344323 Q38171403-3E515B65-3E88-4166-BC05-024AB5DC9AD4 Q38194642-4F26AAFD-BBC5-4A0F-B8E1-92D934429401 Q39870298-E24A4526-28F9-45B9-B58E-F5EEF8A76B59 Q41677096-F6850C33-1FD0-40A2-BAE4-B497FA54502B Q43938442-652DC553-A984-4B65-911D-AA1FD5AE8D02 Q45822881-866375C5-2BF0-45B1-967F-96A908068592 Q46015849-F748B346-DE35-40BB-B260-DB1B8357E29B

P2860

Clinical spectrum of chronic acquired demyelinating polyneuropathies.

http://www.wikidata.org/entity/Q34251202

description

2001 nî lūn-bûn

@nan

2001 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի մարտին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Clinical spectrum of chronic acquired demyelinating polyneuropathies.

@ast

Clinical spectrum of chronic acquired demyelinating polyneuropathies.

@en

Clinical spectrum of chronic acquired demyelinating polyneuropathies.

@nl

type

label

Clinical spectrum of chronic acquired demyelinating polyneuropathies.

@ast

Clinical spectrum of chronic acquired demyelinating polyneuropathies.

@en

Clinical spectrum of chronic acquired demyelinating polyneuropathies.

@nl

prefLabel

Clinical spectrum of chronic acquired demyelinating polyneuropathies.

@ast

Clinical spectrum of chronic acquired demyelinating polyneuropathies.

@en

Clinical spectrum of chronic acquired demyelinating polyneuropathies.

@nl

P1433

Q34251202-91B99611-1E22-4993-B9CE-2953F2305C09

P1476

Q34251202-AB9CF1E6-7ABF-49D9-A1EC-12D0CB506185

P2093

Q34251202-12070A4A-B3BE-4461-899C-A0652A468546

Q34251202-4B3F00E7-BF61-405C-8EBC-B59392A644C9

Q34251202-577FD61A-3542-4835-8007-625E95EDB776

Q34251202-93753F26-A371-4A31-AC94-FFE142FBEF4A

P2860

Q34251202-395C2DC0-FED0-482A-A64D-B8A3E16F0585

Q34251202-4AEAF3FD-A5A3-4179-BA14-D4C624B124AF

Q34251202-74CD1FBD-67F0-4E1D-A04F-45B55846BBBC

Q34251202-A0004873-23BF-43FE-AEEC-3F580390FC99

Q34251202-EE7D7D07-B0C8-46AA-91E1-5249FAD68A12

P304

Q34251202-4F9F8A3A-FBA1-43ED-AB76-7A6A713675A7

P31

Q34251202-8a628adf-8ff4-47eb-bc07-eaa034b12794

Q34251202-9FE7DA82-3483-4341-85F7-1A4B08EF44C9

P356

Q34251202-5ACE9AA3-2083-4F74-B323-712B69DCE464

P433

Q34251202-936B6372-AEA1-4BF8-B605-53D393BA7FBB

P478

Q34251202-E1B3156D-2C52-46DD-A6BD-9F50558B48AB

P577

Q34251202-410429E5-AB3C-4800-B1F8-0ACF17C4D23F

P698

Q34251202-62CCFD39-4AC0-4C17-B8FD-F8C82E0C3241

P356

1097-4598(200103)24:3%3C311::AID-MUS1001%3E3.0.CO;2-A

P1433

Muscle and Nerve

P1476

Clinical spectrum of chronic acquired demyelinating polyneuropathies.

@en

P2093

Amato AA

http://www.w3.org/2001/XMLSchema#string

Barohn RJ

http://www.w3.org/2001/XMLSchema#string

Katz JS

http://www.w3.org/2001/XMLSchema#string

Saperstein DS

http://www.w3.org/2001/XMLSchema#string

P2860

Distal acquired demyelinating symmetric neuropathy.

The sensitivity and specificity of anti-GM1 antibody testing.

Multifocal motor neuropathy with conduction block: is it a distinct clinical entity?

Polyneuropathies associated with IgM monoclonal gammopathies.

Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance.

P304

311-324

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2001-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11353415

http://www.w3.org/2001/XMLSchema#string